JPRN-UMIN000012818
Completed
Phase 1
A phase I/II study of preoperative chemoradiotherapy with S-1, Celecoxib and Radiation for locally advanced rectal cancer - chemoradiotherapy with S-1, Celecoxib and Radiation for locally advanced rectal cancer
Department of frontier surgery Graduate school of medicine, Chiba University0 sites20 target enrollmentJanuary 10, 2014
ConditionsRectal cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Rectal cancer
- Sponsor
- Department of frontier surgery Graduate school of medicine, Chiba University
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\). Even if is an overlap cancer case of the activity or heterochrony; a treatment\-free and disease\-free period the case (but cancer in the epithelium and the skin cancer are excluded) less than five years 2\). It is a case with a history of the radiation therapy including the irradiation after art for a lesion 3\). with the diarrhea (water\-like flight) 4\). receiving flucytosine 5\). It is a case with the past of hypersensitivity for S\-1, an ingredient of celecoxib 6\). The case (diabetes having poor heart, kidney, liver failure, control) with serious complications 7\). Aspirin asthma or a case with the past 8\). with peptic ulcer of the activity 9\). uses an NSAID regularly 10\). hydrothorax, abdominal dropsy to need urgent treatment 11\). having an infectious disease of the activity few for tumor in itself 12\). having the intestinal tract paralysis, ileus 13\). with the possibility (intention) of the pregnancy, a pregnant woman or a nursing girl, a case without the intention to prevent conception 14\). A perioperative patient of the coronary bypass rebuilding art 15\). In addition, the case that I judged to be inappropriate though the examination medical attendant carried out the final examination safely
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Phase I/II study of preoperative chemoradiotherapy with Gemcitabine and S-1 for resectable pancreatic cancerJPRN-UMIN000002649Multicenter Clinical Study Group of Osaka63
Completed
N/A
A phase I/II trial of preoperative chemoradiotherapy with gemcitabine in patients with pancreatic cancer and impaired renal functioJPRN-UMIN000016877Clinical Study Group of Osaka University8
Recruiting
Phase 2
A pilot study of the preoperative chemoradiotherapy for T3-4, N0-N2 rectal cancer aiming at sphincter preservation.Rectal cancerJPRN-UMIN000009432Saitama Medical Center, Saitama Medical University28
Active, Not Recruiting
Phase 1
Chemoradiotherapy plus avelumab in locally advanced rectal cancerocally advanced rectal cancerMedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003582-10-ITG.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST101
Completed
Phase 2
Phase II study of pre-operative chemoradiation using S-1 followed by surgical resection for potentially resectable and locally advanced pancreatic cancerPotentially resectable and locally advanced pancreatic cancerJPRN-UMIN000003088Department of Surgery, Kansai Medical University Hirakataka Hospital30